EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Esmolol in Neonatal Cardiac Surgery with Cardiopulmonary Bypass (CPB) for d-Transposition of the Great Arteries (d-TGA)

Anna-Eva Blank, Thomas Zajonz, Inga Gruschwitz, Christoph Neuhäuser, Hakan Akintürk, Christian Jux, David Backhoff

Pediatric Cardiology · 2025

DOI: 10.1007/s00246-024-03671-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Cardiology, 2025. Verfasst von Anna-Eva Blank und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology, Pediatric Heart Center, Justus-Liebig University Giessen, Giessen, Germany. anna-eva.blank@paediat.med.uni-giessen.de. Hauptthemen laut MEDLINE: Propanolamines, Transposition of Great Vessels, Heart Rate, Adrenergic beta-1 Receptor Antagonists. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

D-Transposition of the great arteries (d-TGA) is the most common congenital heart disease requiring surgical correction within the neonatal period. Sinus tachycardia often persists postoperatively, potentially affecting cardiac function. This study aimed to investigate the efficacy and safety of the short-acting beta-1-selective beta-blocker esmolol in controlling heart rate in neonatal cardiac surgery with cardiopulmonary bypass (CPB).

Methods

A retrospective cohort study was conducted on neonates undergoing surgery for d-TGA. The study cohort included 112 patients, divided into an esmolol intervention group ( n = 57) and a control group ( n = 55). Baseline characteristics, hemodynamic parameters and outcome measures were assessed.

Results

In the esmolol group, median heart rate at ICU admission was significantly higher compared to the control group (155 vs. 147 bpm, p = 0.018). After a median time of 11 h, heart rate was lower among the esmolol patients (135 vs. 144 bpm, p < 0.001). There were no differences in other hemodynamic parameters between the two groups. Patients treated with esmolol required longer catecholamine support while no difference regarding survival, duration of invasive ventilation and ICU stay were noticed.

Conclusion

No relevant hemodynamic difference was seen between neonates treated with perioperative esmolol and the control group and outcome did not differ. This indicates non-inferiority of perioperative betablocker therapy in young age. Prospective and placebo-controlled assessment of perioperative esmolol therapy in neonates is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropanolaminesTransposition of Great VesselsHeart RateAdrenergic beta-1 Receptor AntagonistsCardiopulmonary BypassCardiac Surgical ProceduresHumansMaleRetrospective StudiesFemaleInfant, NewbornTreatment OutcomeHemodynamics

Stichwörter der Autor:innen

Beta-blockerCongenital heart diseaseEsmololNeonatal cardiac surgeryNeonatal intensive careTransposition of the great arteries

Substanzen

esmololPropanolaminesAdrenergic beta-1 Receptor Antagonists

Autor:innen und Institutionen

  • Pediatric Cardiology, Pediatric Heart Center, Justus-Liebig University Giessen, Giessen, Germany. anna-eva.blank@paediat.med.uni-giessen.de.
  • Department of Pediatric Cardiology, Intensive Care Medicine and Congential Heart Disease, Pediatric Heart Center, Justus-Liebig University Giessen, Feulgenstr. 10-12, 35392, Giessen, Germany. anna-eva.blank@paediat.med.…
  • Pediatric Anesthesiology, Pediatric Heart Center, Justus-Liebig University Giessen, Giessen, Germany.
  • Pediatric Cardiology, Pediatric Heart Center, Justus-Liebig University Giessen, Giessen, Germany.
  • Pediatric Cardiac Surgery, Pediatric Heart Center, Justus-Liebig University Giessen, Giessen, Germany.

Förderung

  • Justus-Liebig-Universität Gießen

Zitieren

APA

Blank, A. E., Zajonz, T., Gruschwitz, I., Neuhäuser, C., Akintürk, H., Jux, C., & Backhoff, D. (2025). Efficacy and Safety of Esmolol in Neonatal Cardiac Surgery with Cardiopulmonary Bypass (CPB) for d-Transposition of the Great Arteries (d-TGA). Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03671-x

Vancouver

Blank AE, Zajonz T, Gruschwitz I, Neuhäuser C, Akintürk H, Jux C, et al. Efficacy and Safety of Esmolol in Neonatal Cardiac Surgery with Cardiopulmonary Bypass (CPB) for d-Transposition of the Great Arteries (d-TGA). Pediatric Cardiology. 2025. doi:10.1007/s00246-024-03671-x

BibTeX
@article{Blank2025,
  author = {Blank, Anna-Eva and Zajonz, Thomas and Gruschwitz, Inga and Neuhäuser, Christoph and Akintürk, Hakan and Jux, Christian and Backhoff, David},
  title = {Efficacy and Safety of Esmolol in Neonatal Cardiac Surgery with Cardiopulmonary Bypass (CPB) for d-Transposition of the Great Arteries (d-TGA)},
  journal = {Pediatric Cardiology},
  year = {2025},
  doi = {10.1007/s00246-024-03671-x}
}
Kostenlos starten →